MPM ASSET MANAGEMENT LLC

CIK 1263048 · last filed 2026-01-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$185.44M

Companies

3

Total Filings

26

Lifetime Open-Market Net

$56.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKTS 10%+ Owner 7,570,168 $24.21 $183.27M $60.09M 1 2026-01-14
HOWL 10%+ Owner 4,784,111 $0.45 $2.17M -$3.93M 3 2025-12-04
EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted 10%+ Owner 14,633,961 $0 1 2010-01-04

Recent Filings · Page 3 of 3

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-04 HOWL Notice (144) −20,597 -$27.0K EDGAR
2025-10-30 HOWL Notice (144) −20,597 -$32.1K EDGAR
2025-10-27 HOWL Notice (144) −20,597 -$36.5K EDGAR
2011-10-21 Sell (S) −3,678,536 -$3.79M
2011-10-06 Sell (S) −3,041,856 -$3.10M
2010-01-04 EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted Other (J) −63,309,224 $0 EDGAR
Showing 2126 of 26
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.